The corpus luteum (CL) is a transient ovarian endocrine gland formed from the ovulated follicle. Progesterone is the primary secretory product of CL and is essential for establishment of pregnancy in mammals. In the cyclic female, the life span of CL is characterized by luteal development, maintenance, and regression regulated by complex interactions between luteotrophic and luteolytic mediators. It is universally accepted that prostaglandin (PG) F 2a is the luteolysin whereas PGE 2 is considered as a luteotropin in most mammals. New emerging concepts emphasize the autocrine and paracrine actions of luteal PGs in CL function. However, there is no report on selective biosynthesis and cellular transport of luteal PGE 2 and PGF 2␣ in the CL of any species. We have studied the expression of enzymes involved in the metabolism of PGE 2 and There are at least two steroidogenic cell types: large luteal cells (LLCs) of granulosa cell origin and small luteal cells (SLCs) of theca cell origin. The primary secretory product of the CL is progesterone (P 4 ), which is essential for establishment and maintenance of pregnancy as well as ovarian cyclicity in most mammals. Defects in luteal function have been associated with infertility, abortion, and ovarian cycle disorders. Mechanisms involved in the control of CL life span and function have been reviewed extensively (1-5). In the cyclic female, the life span of CL is characterized by luteal development, maintenance, and regression (luteolysis). The life span and function of the CL is regulated by complex interactions between stimulatory (luteotrophic) and inhibitory (luteolytic) mediators. It is universally accepted that prostaglandin (PG) F 2␣ is the luteolysin in most mammals investigated. Surgical removal of the uterus (hysterectomy) prolongs the life span of the CL in cyclic sheep, cattle, pig, horse, and guinea pig and in the pseudopregnant hamster, rabbit, and rat providing evidence that luteolytic PGF 2␣ is of uterine/endometrial origin in these species. The endometrial PGs reach the CL by local, systemic, or a combination of both mechanisms depending on the species. By contrast, in primates and humans, hysterectomy does not prolong either the length of the ovarian cycle or the life span of the CL suggesting that luteolytic PGF 2␣ is not of uterine origin. In these species, it has been proposed that autocrine and paracrine action of luteal PGs may be involved in the control of CL life span and function. Intraluteal production of PGs has been reported in cattle, sheep, pigs, and rats, supporting a role for luteal PGs in CL function in these species as well. Luteal regression proceeds in two steps: the decrease in P 4 is considered as functional luteolysis, and the luteal involution is described as structural luteolysis (1-4). Recent studies have proposed that endometrial/extraluteal PGF 2␣ initiates functional luteolysis whereas luteal PGF 2␣ may contribute to structural luteolysis (4, 6).
T HE CORPUS LUTEUM (CL) is a transient ovarian en-
docrine gland formed from the ovulated follicle. The mature CL is composed of heterogeneous cell population. There are at least two steroidogenic cell types: large luteal cells (LLCs) of granulosa cell origin and small luteal cells (SLCs) of theca cell origin. The primary secretory product of the CL is progesterone (P 4 ), which is essential for establishment and maintenance of pregnancy as well as ovarian cyclicity in most mammals. Defects in luteal function have been associated with infertility, abortion, and ovarian cycle disorders. Mechanisms involved in the control of CL life span and function have been reviewed extensively (1) (2) (3) (4) (5) . In the cyclic female, the life span of CL is characterized by luteal development, maintenance, and regression (luteolysis). The life span and function of the CL is regulated by complex interactions between stimulatory (luteotrophic) and inhibitory (luteolytic) mediators. It is universally accepted that prostaglandin (PG) F 2␣ is the luteolysin in most mammals investigated. Surgical removal of the uterus (hysterectomy) prolongs the life span of the CL in cyclic sheep, cattle, pig, horse, and guinea pig and in the pseudopregnant hamster, rabbit, and rat providing evidence that luteolytic PGF 2␣ is of uterine/endometrial origin in these species. The endometrial PGs reach the CL by local, systemic, or a combination of both mechanisms depending on the species. By contrast, in primates and humans, hysterectomy does not prolong either the length of the ovarian cycle or the life span of the CL suggesting that luteolytic PGF 2␣ is not of uterine origin. In these species, it has been proposed that autocrine and paracrine action of luteal PGs may be involved in the control of CL life span and function. Intraluteal production of PGs has been reported in cattle, sheep, pigs, and rats, supporting a role for luteal PGs in CL function in these species as well. Luteal regression proceeds in two steps: the decrease in P 4 is considered as functional luteolysis, and the luteal involution is described as structural luteolysis (1) (2) (3) (4) . Recent studies have proposed that endometrial/extraluteal PGF 2␣ initiates functional luteolysis whereas luteal PGF 2␣ may contribute to structural luteolysis (4, 6) . PGE 2 plays many roles in different mammalian systems: mitogenesis, angiogenesis, antiapoptosis, and vasodilation etc. In the female reproductive system, PGE 2 has been considered as luteoprotective or luteotrophic in a variety of species since the late 1970s (7, 8) . Intrauterine administration of PGE 2 protects the CL from spontaneous and/or induced luteolysis in ruminants (7) (8) (9) (10) . PGE 2 stimulates luteal P 4 secretion through a cAMP-mediated pathway in human, rabbit, and ruminant CL (11) (12) (13) (14) (15) . When indomethacin was used to inhibit luteal PG production, it reduced P 4 secretion in ewes (16) . Moreover, a positive correlation between luteal PGE 2 and P 4 has been demonstrated during the menstrual cycle in humans (17) and the estrous cycle in cows (13) . Furthermore, intraluteal metabolism of P 4 is an important factor determining the circulating concentration of P 4 (4) . In rat and rabbit CLs, it has been demonstrated that 20␣-hydroxysteroid dehydrogenase (20␣-HSD) converts P 4 into the inactive progestin 20␣-hydroxyprogesterone (18 -20) . This functional alteration of P 4 secretion and CL function through 20␣ HSD activity has not been described in other species (4) .
It is evident from the available information that both PGE 2 and PGF 2␣ play key roles in CL function. It has been suggested that luteal tissues or cells possess an inherent capacity to produce PGs in most mammalian species (21) . The CL has a rich source of arachidonic acid (AA) (5), an essential fatty acid stored in membrane phospholipids and the primary precursor of all PGs (22) . The net production of individual PGs is controlled by several enzymes such as cytosolic phospholipase A 2 (cPLA 2 ), cyclooxygenases (COX), PG synthases, and PG 15-dehydrogenase (PGDH). cPLA 2 liberates AA from phospholipids. COX-1 and COX-2 convert AA into PGH 2 , the common intermediate metabolite for various forms of PGs including PGE 2 and PGF 2␣ . The downstream enzymes, PGE synthase (PGES) and PGF synthase (PGFS), catalyze the conversion of PGH 2 to PGE 2 and PGF 2␣ , respectively (22) . Current evidence suggests three forms of PGES; among them, microsomal PGES-1 (mPGES-1) is highly inducible along with COX-2 (23). We have found that an aldoketoreductase 1B5 (AKR1B5) possessing 20␣-HSD activity is the PGFS involved in the production of PGF 2␣ in bovine endometrium at the time of luteolysis (24) . Catabolism of PGs is governed by PGDH converting PGE 2 and PGF 2␣ into inactive PGEM (PGE 2 metabolite) and PGFM (PGF 2␣ metabolite), respectively (25) . COX-1, COX-2, and PGDH mRNAs are expressed in the sheep CL (26, 27) . It has been demonstrated that PGF 2␣ treatment increases COX-2 expression and luteal production of PGF 2␣ in ruminants (26) . However, no information is available on expression and regulation of PGES and PGFS in CL.
PGE 2 and PGF 2␣ exert their effects primarily through the G protein-coupled receptors designated EP and FP, respectively. There are four EP receptor subtypes EP1, EP2, EP3, and EP4, and two FP receptor subtypes FP A and FP B . EP2 and EP4 receptors are coupled to adenylate cyclase activating cAMP that in turn activates the protein kinase A (PKA) signaling pathway. EP1 and FP receptors are coupled to phospholipase C (PLC) generating two second messengers, inositol triphosphate (IP 3 ) involved in the liberation of intracellular calcium (Ca 2ϩ ) and diacyl glycerol, an activator of protein kinase C (PKC). There are four isoforms of EP3 receptors designated from A to D. These EP3 receptors exhibit a wide range of action from inhibition of cAMP production to increases in Ca 2ϩ and IP 3 (28) . Expression and regulation of FP has been extensively studied in luteal steroidogenic cells, but information pertaining to EP is largely unknown (29 -31) .
It was initially thought that due to their lipid nature PGs would freely cross cell membranes like steroids. However, PGs predominate as charged anions and diffuse poorly through plasma membranes. Prostaglandin transporter (PGT) mediates both the efflux of newly synthesized PGs to effect their biological actions through their cell surface receptors, and influx of PGs from the extracellular milieu for their inactivation (32, 33) . We have unraveled the role of PGT in reproductive function for the first time in mammals (34) . Our findings have suggested that PGT is involved in cellular transport of PGE 2 and PGF 2␣ within the uterine tissues and in their transport from the uterus to the ovary through the uteroovarian plexus in bovine. Because of the strategic role played by PGs in the regulation of CL function, it appears important to evaluate the contribution of PGT in luteal tissue.
The bovine species is ideally suited to study the role of PGs in the regulation of CL function. In cyclic cow, the CL goes through distinct growing, mature, and regressing phases during its life span, and these have to be studied individually. The cow is a nonseasonal polyestrous animal relatively having a long cycle of 21 d similar to the 28-d human cycle. The bovine CL provides a large volume of luteal tissue easily accessible without ethical concerns. Recently, we have developed most of the molecular tools necessary to explore PGs functions in the bovine reproductive system. We have documented previously the expression and regulation of COX-1, COX-2, PGFS, PGES, PGDH, and PGT as well as PG receptors EP2, EP3, EP4, and FP in uterine tissues during the estrous cycle and pregnancy in the bovine (24, 34 -38) .
New concepts that have emerged in recent years regarding the autocrine and paracrine roles of PGs in CL might have important implications in luteal physiology (3, 4, 21) . However, lack of evidence on cell-specific expression of various components of PGE 2 and PGF 2␣ biosynthetic, transporting, and signaling machineries remains a major limitation in our understanding of CL function. Therefore, the objectives of the present study were to evaluate concurrently the expression of 1) PG's biosynthetic enzymes COX-1, COX-2, mPGES-1, and PGFS (AKR1B5); 2) PG's catabolic enzyme PGDH; 3) PG's transporter PGT, and 4) PG receptors EP2, EP3, and FP in CL during different phases of its life span.
Materials and Methods Materials
The numerous reagents necessary for this study were purchased from the following suppliers: Superscript II RT, DNA and RNA ladders, dithiothreitol, T4 kinase, 5ϫ forward reaction and first strand buffers, and TRIzol (Invitrogen Life Technologies Inc., Burlington, Ontario, Canada); Random primer-pd(N)6, deoxynucleotide triphosphates, RNA guard, rTaq DNA polymerase, PCR 10ϫ buffer, and Ready-To-Go DNA Labeling Kit (Amersham Pharmacia Biotech, Montreal, Québec, Canada); prestained protein markers (New England Biolabs Inc., Mississauga, Ontario, Canada); Bright Star-Plus nylon membrane and UltraHyb (Ambion Inc., Austin, TX); Trans-Blot nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA); [␥ 32 P]ATP and [␣ 32 P]dCTP (PerkinElmer Life Sciences, Markham, Ontario, Canada); Renaissance (Life Science Products Inc., Boston, MA); BioMax film (Eastman Kodak Corp, New York, NY); plasmid and mRNA purification kits (QIAGEN Inc., Mississauga, Ontario, Canada); Mayer's hematoxylin (SigmaAldrich Canada Ltd., Oakville, Ontario, Canada); LightCycler FasterStart DNA Master SYBR Green I mix and MgCl 2 (Roche Diagnostics, Laval, Québec, Canada); and Vectastain Elite ABC Kit (Vector Laboratories Inc., Burlingame, CA). All oligonucleotide primers were chemically synthesized using ABT 394 synthase (PerkinElmer, Foster City, CA). The other chemicals used were molecular biological grade available from Laboratoire Mat or Fisher Biotech (Québec City, Québec, Canada). Goat antirabbit biotinylated Ig (Dako Diagnostics of Canada Inc., Mississauga, Ontario, Canada); goat antirabbit or mouse IgG conjugated with horseradish peroxidase (Jackson ImmunoResearch Laboratories, West Grove, PA); monoclonal antimouse ␤-actin antibody and antihuman rabbit EP2 polyclonal antibody (Cayman Chemicals, Ann Arbor, MI) were purchased. Antibodies against bovine PGES (39), PGFS (24) , PGDH (38) , and PGT (34) were produced in our laboratories as described previously. Antisheep COX-1 and COX-2 antibodies were donated by Dr. Stacia Kargman (Merck-Frost, Montreal, Canada).
Experimental design
Uteri were collected along with the ovaries from cyclic cows at a local abattoir. Days of the estrous cycle were determined by uteroovarian morphology as described previously (36) and classified into seven groups covering the entire cycle length: d 1-3 (n ϭ 4); 4 -6 (n ϭ 3); 7-9 (n ϭ 3); 10 -12 (n ϭ 3); 13-15 (n ϭ 6); 16 -17 (n ϭ 7); and 18 -21 (n ϭ 5). CLs were separated by blunt dissection from the surrounding ovarian tissues. Cross-sections of tissues were prepared and processed for immunohistochemistry as described below. Tissues were cut into small pieces and snap-frozen in liquid nitrogen and stored at Ϫ80 C until used. Total RNA was isolated using TRIzol according to the manufacturer's protocol. Total proteins were extracted and quantified as we described (36) . Expression of COX-1, COX-2, and PGT mRNA was studied using Northern blot analysis. COX-1, COX-2, PGES (mPGES-1), PGFS (AKR1B5), PGDH, PGT, and EP2 proteins were studied by Western blot analysis. EP2, EP3, and FP mRNAs were studied using real time quantitative RT-PCR (LightCycler). Cellular localization of COX-2, PGES, PGFS, PGDH, PGT, and EP2 proteins were performed by immunohistochemistry.
Quantitative RT-PCR (LightCycler)
LightCycler reaction using SYBR Green I (Roche Applied Science) and quantifications were performed as we described (37) . In brief, total RNA (1 g) was reverse transcribed using random primer and Superscript II RT. Sets of specific primers were deduced from the known sequences of bovine EP2, EP3, EP4, and FP. LightCycler reactions were performed in a total volume of 20 l in microcapillary tubes according to the manufacturer's instructions. Recombinant plasmids containing specific inserts of EP2, EP3, and FP, and the purified PCR product for glyceraldehyde-3-phosphate dehydrogenase were used as templates. The plasmid DNAs or PCR products were quantified and serially diluted from 100 -0.01 pg /2 l. Each reaction mixture contained 2 l of cDNAs, 2 l FasterStart DNA Master SYBR Green I mix, 2 l of sense and antisense primers each (0. 
Northern blot analysis
Northern blotting and hybridization were performed as we described (36) Briefly, total RNA (ϳ20 g) was loaded in each lane and electrophoresed on 1.2% formaldehyde-agarose gel. RNA was transferred overnight onto a nylon membrane in 10ϫ saline sodium citrate (SSC). The cDNA probes for COX-1, COX-2, and PGT were labeled with [␣ 32 P] dCTP (3000 Ci /mmol) using the Ready-To-Go DNA Labeling Kit. Prehybridization (2-3 h) and hybridization (overnight) were carried out at 45 C using UltraHyb. The blots were stripped off by boiling in 1% SDS for 30 min and rehybridized with ␥ 32 P[ATP]-labeled oligoprobe specific to 18S ribosomal RNA. The blots were exposed to BioMax film and densitometry of autoradiograms was performed using an Alpha Imager (Alpha InnotechCorp., Montreal, Québec, Canada). Bovine COX-1 and COX-2 (36) and PGT cDNAs (34) were obtained and used as probes as described previously.
Western blot analysis
Western blot analysis was performed as we described (36) . Briefly, total proteins (ϳ20 g) were loaded in each lane and electrophoresed on 10% SDS-PAGE followed by electrotransfer onto nitrocellulose membrane. The following primary antibodies (raised in rabbit) were used for the respective protein: antisheep COX-1 and COX-2 (1:3000), antibovine PGES (1:2000), PGFS (1:3000), PGDH (1:2000), PGT (1:1000), and antihuman EP2 (1:500). Goat antirabbit IgG conjugated with horseradish peroxidase was used as the secondary antibody (1:20000). Chemiluminescent substrate was applied according to the manufacturer's instructions (Renaissance, Life Science Products, Inc.). The blots were exposed to BioMax films and densitometry was done using an Alpha Imager. As an internal standard, ␤-actin (1:5000) was measured.
Immunohistochemistry
Cross-sections were made in the middle portion of the CL. Tissues were fixed in 4% buffered paraformaldehyde for 4 h at 4 C and processed using standard procedures. Paraffin sections (3 m) were made. Immunohistolocalization was performed using Vectastain Elite ABC Kit according to the manufacturer's protocols, and as described (35, 36) . Endogenous peroxidase activity was removed by fixing sections in 0.3% hydrogen peroxide in methanol. Tissue sections were blocked in 10% goat serum for 1 h at room temperature. The primary antibodies were the same as described above. The following concentrations were used: COX-2 (1:2000), PGES (1:500), PGFS (1:1000), PGDH (1:2000), PGT (1: 500), and EP2 (1:500). Incubation with the primary antibodies was done overnight at 4 C. The sections were further incubated with the second antibody (goat antirabbit IgG biotinylated, 1:200) for 30 min at room temperature. For the negative control, preimmune or control rabbit serum was used at the respective dilution used for primary antibodies. Between each step, tissues were washed in PBS. Finally, tissues were stained with Mayer's hematoxylin. Photos were captured using the Spot Program (Carsen Group Inc., Markham, Ontario, Canada). [Preimmune serum was used for the antibodies produced in our laboratory (PGFS, PGDH, PGT), and control serum was used for commercial and donated antibodies (COX-2, EP2, PGES) (control serum is the one collected without immunization from the same species in which the antibody was raised)].
Statistical analysis
All numerical data were presented as the mean Ϯ sem. Data were analyzed using two-way ANOVA followed by Scheffé's tests (Super Anova, Abacus Concepts, Inc., Berkeley, CA). Differences were considered as statistically significant at the 95% confidence level (P Ͻ 0.05).
Results

Expression of COX-1 and COX-2
Maximal (P Ͻ 0.05) expression of COX-2 mRNA and protein occurs on d 7-17 and 10 -21 of the estrous cycle, respectively. By contrast, COX-1 mRNA and protein are expressed at constant low levels during the entire life span of CL (Fig.  1) . Cellular localization shows that COX-2 protein is expressed in LLCs but not in SLCs and other cell types (see 
Expression of PGES, PGFS, and PGDH
Relative expression shows that PGES protein is highly modulated whereas PGFS and PGDH proteins are expressed at steady-state levels during different phases of the CL life span (Fig. 2) . The expression level of PGES is higher than that of PGFS in growing, lower in regressing, and equal in mature CLs. Immunohistochemistry shows that PGES and PGFS proteins are localized exclusively in LLCs (see Fig. 5 ), whereas PGDH is undetectable (data not shown). Comparatively, PGES staining intensity decreases in mature and regressing CL compared with growing CL whereas no difference is observed for PGFS. As an indication of the relative impor-tance of PGE 2 and PGF 2␣ production, the PGES to PGFS ratio is presented. Similarly, the relative PG anabolism to catabolism is shown as PG synthases to PGDH ratio. The data indicate that the PGES to PGFS ratio is high (P Ͻ 0.05) on d 1-12 compared with d 13-21 of the estrous cycle. The PGES to PGDH ratio is elevated between d 1 and 12, whereas the PGFS to PGDH ratio is stable and high at all times except on d 1-3 (P Ͻ 0.05).
Expression of PGT
The level of expression of PGT mRNA and protein is higher (P Ͻ 0.05) on d 7-21 than d 1-6 of the estrous cycle (Fig. 3) . The maximal (P Ͻ 0.05) expression is observed on d 13-15. PGT protein is highly expressed in LLCs (see Fig. 5 ). The staining intensity for PGT protein is similar in growing, mature, and regressing CLs.
Expression of EP2, EP3 and FP
The level of expression of PG receptor mRNAs are FP Ͼ Ͼ EP3 Ͼ EP2 (P Ͻ 0.05) throughout the CL life span (Fig. 4) . EP2 mRNA expression is high (P Ͻ 0.05) on d 4 -15, moderate on d 16-21, and low on d 1-3 of the estrous cycle. EP2 protein expression follows that of mRNA except on d 13-15 , on which it begins to decrease. Cellular localization shows that EP2 protein is highly expressed in LLC (Fig. 5) . Comparatively, the staining intensity for EP2 protein is higher in growing than in mature and regressing CLs. EP3 mRNA expression is low on d 1-6, increases on d 7, and reaches its maximum between days 10 and 21 (P Ͻ 0.05). The concentration of FP mRNA progressively increases from d 1-9, reaches peak on d 10 -12 (P Ͻ 0.05), and decreases from d 13 onward.
Discussion
We present here an integrated view of PGE 2 and PGF 2␣ biosynthesis, transport, and signaling in the CL. Our results show that the bovine CL possesses all of the PGE 2 and PGF 2␣ machineries necessary for autoregulation of its function. The net production and action of PGE 2 and PGF 2␣ in a given tissue is governed by several components such as anabolic and catabolic enzymes, transporters, and receptors. Among those, cPLA 2 , COX-1, COX-2, PGDH, and PGT are involved in nonselective production and transport of PGs whereas PG synthases E and F (PGES and PGFS) and receptors (EP and FP) control the selective production and the associated distinct biological actions. We have characterized the expression of both selective and nonselective components in the CL and found that PGE 2 and PGF 2␣ machineries are selectively and specifically expressed in CL. Our findings suggest a contribution of locally produced luteal PGs that may complement the classical paradigm of endometrial/extraluteal PG influence on CL function.
COX-2 and PGES are highly modulated whereas COX-1, PGFS, and PGDH are expressed at a constant level during the CL life span. Relative expression of these enzymes demonstrates that, relative to PGF 2␣ , PGE 2 biosynthesis is higher in growing, lower in regressing, and similar in mature CL. Cellular localization of COX-2, PGES, and PGFS proteins indicates that PGE 2 and PGF 2␣ biosynthesis preferentially occurs in LLCs compared with other cell types. Other studies reported that COX-1 required higher concentration of AA than does COX-2 to exert its function, and different pools of AA could be used by the two isoforms of COXs (22, 23, 40) . This may explain the distinct role of COX-1 and -2 in the conversion of AA to PGH 2 . It has been estimated based on specificity constant (K cat /K m ) that conversion of PGH 2 to PGE 2 by mPGES-1 is 150-fold higher than conversion of PGH 2 to PGF 2␣ by PGFS (AKR1B5) (23, 24) . It suggests that although PGES and PGFS are expressed at the same level in a given tissue, PG biosynthesis is preferentially directed toward PGE 2 rather than PGF 2␣ production. Together, expression patterns of PGs metabolic enzymes in the CL suggest that intraluteal PG biosynthesis is selectively directed toward PGE 2 during growth, toward PGF 2␣ during regression, and is nonselective during the mature phase of the CL life span.
Newly synthesized luteal PGE 2 and PGF 2␣ must flow out of luteal cells to bring forth their autocrine and paracrine actions. Recently, it has been shown that although PGs cross the membrane by simple diffusion, the estimated flow rate is too low to exert a biological function (41) . Therefore, a carrier-mediated transport mechanism is needed for PGs to cross the biological membranes (32, 33) . We have very recently demonstrated that bovine PGT facilitates efflux and influx of PGE 2 and PGF 2␣ with equal affinities in a competitive manner (34) . Interestingly, in bovine endometrium PGT is highly expressed when PG production and action is higher. PGT expression also closely matches the pattern of expression of PG biosynthetic enzymes and receptors (24, 34 -36) . In the present study, luteal expression of PGT is lower in early growing (d 1-6) than in late growing, mature, and regressing phases. PGT is almost exclusively expressed in LLCs. The expression pattern of PGT along with PG metabolic enzymes suggests that PGT expression is not associated with a particular PG pathway. Rather, we believe that PGT facilitates both efflux and influx of available luteal PGE 2 and/or PGF 2␣ in a competitive manner to affect their autocrine and paracrine actions, as well as their catabolism during the different phases of CL life span. However, a detailed functional study in luteal cells would be needed to define PGT contribution to CL function.
Expression of EP2 and EP3 shows a contrasting pattern in growing, mature, and regressing CL. EP2 protein is highly expressed in LLCs and to a lesser extent in SLCs. The EP2 expression pattern closely matches that of PGES. Recently, we have identified EP2 and not EP4 as the major cAMPgenerating PGE 2 receptor expressed in bovine reproductive tissues including the CL (35) . In this study, we have analyzed EP3 mRNA with no distinction of the four isoforms. The existence of different EP3 subtypes does not permit at the present time to relate our results to a specific signaling pathway in CL. Others have found that EP3 mRNA is not expressed in LLCs of ovine CL (31) . Taken together, available evidence suggests that PGE 2 probably uses both EP2 and EP3 receptors subtypes to accomplish distinct purposes at different phases of CL life span as it has been shown in other systems (42) . In the present investigation, FP expression increases in growing and decreases in mature and regressing CLs as it was reported by others (30, 31) . They have found that FP receptor is primarily localized in LLCs and to some extent in SLCs in ruminants where PGF 2␣ treatment also decreases FP mRNA in LLCs.
Maintenance of CL and P 4 secretion is the prerequisite for establishment of pregnancy in most mammals. PGE 2 stimulates P 4 secretion with an efficiency comparable to LH in bovine and ovine CL (12, 16, 43) . Accumulating evidence indicates that PGE 2 increases luteal P 4 secretion by activating the cAMP-PKA pathway in human, rabbit, and ruminant CLs (11) (12) (13) (14) (15) . Moreover, a positive correlation between luteal PGE 2 and P 4 has been demonstrated during the menstrual cycle in humans (17) and the estrous cycle in cows (13) . Most mitogenic, angiogenic, vasodilatory, and antiapoptotic activities of PGE 2 are mediated through cAMP in a variety of cells and tissues (44, 45) . PGE 2 increases COX-2 and EP2 expression, thereby autoregulating its own production and action in different cell types (44 -46) . On the other hand, regular ovarian cyclicity requires the regression of CL and decrease in P 4 . The signaling pathways leading to luteal regression are more complex and greatly differ among species. The pleiotropic action of PGF 2␣ and FP signaling in luteal regression has been reviewed extensively (3, 29) . Activation of FP increases intracellular PKC and Ca 2ϩ to effect luteal regression (1) (2) (3) (4) . Increase in PKC results in decreased secretion of P 4 (functional luteolysis) and Ca 2ϩ is involved in apoptosis and cell death (structural luteolysis) (3, 4, 29, 31) . It has been reported that FP mRNA is temporally associated with the decrease in luteal mass and luteal P 4 concentration (47, 48) . A new FP receptor (FP B ) has been identified recently. Although the physiological role of the conventional FP A is well defined, a possible role for FP B has not been explored in the CL (49) . It has been demonstrated that FP B increases COX-2 expression through a Rho, but not PKC, signaling pathway (50) . Recent studies have suggested that endometrial/extraluteal PGF 2␣ triggers intraluteal production of PGF 2␣ to complete the luteolytic process (6, 26) . Others have proposed that PGF 2␣ increases luteal PGE 2 , which augments the luteolytic effect of PGF 2␣ through EP3 by an autocrine/ paracrine action in the regressing CL (6, 51) . The present findings showing selective activation of PGE 2 biosynthesis and EP2 signaling during luteal maintenance and increased expression of PGFS and EP3 during luteal regression greatly support the new emerging concept that, after action of extraluteal/ endometrial PGs, contribution from local (luteal) sources participate to the regulation of CL function and life span.
Intraluteal metabolism of P 4 may be an important factor contributing to luteal regression. It has been suggested that, in the rat, CL 20␣-HSD activity is down-regulated by P 4 and up-regulated by PGF 2␣ (19, 20) . The PGFS (AKR1B5) we have evaluated in this study also possesses 20␣-HSD activity. In the cow, although AKR1B5 expression is constant throughout the CL life span, high intraluteal concentration of P 4 may block both the 20␣-HSD and PGFS activities during the growing and mature phases. When endometrial/extraluteal PGF 2␣ initiates functional luteolysis, the decrease in P 4 would clear the inhibition and allow this enzyme to further decrease P 4 and increase luteal PGF 2␣ production, thus creating an amplification loop leading to luteal regression.
In cyclic cows, endometrial PGF 2␣ initiates the luteolytic process between d 15 and 17; by contrast, endometrial PGE 2 may rescue the CL in the presence of a viable embryo (1, 2) . Intrauterine or intraluteal administration of PGE 2 during this window counteracts the luteolytic effect of PGF 2␣ and increases life span of the CL (1, 2, 7-10). The underlying regulatory mechanisms may involve intraluteal factors. It is evident from the present study that PGE 2 and PGF 2␣ factories are selectively localized in LLCs. It is well known from other studies that, in ruminants, more than 80% of total P 4 is produced from LLCs and independent of LH (4, 52). The mechanism responsible for the large amount of P 4 produced by LLCs remains to be elucidated (52) . With accumulating evidence on PGE 2 and luteal P 4 in other species (11) (12) (13) (14) (15) , the presence of PGE 2 biosynthetic, transporting, and EP2 signaling machineries in LLCs point to PGE 2 as the candidate involved in the stimulation of P 4 production from LLCs during luteal maintenance in cattle. On the other hand, down-regulation of PGE 2 biosynthesis and EP2 signaling gives way to develop PGF 2␣ biosynthesis and FP signaling during luteal regression. In ruminants, the mechanism responsible for refractoriness of early CL to luteolytic PGF 2␣ is poorly understood. It has been proposed that higher PGDH activity could account for low intraluteal concentration of PGF 2␣ (26, 27) . But, in the present study, we have shown that PGDH protein is present throughout the estrous cycle at constant low levels. On the other hand, we show here that expression of PGT is low and that PGE 2 biosynthesis and signaling pathways are high in the growing CL. Thus, limited availability of PGT and increased PGE 2 production and action may explain refractoriness of early CL to luteolysis in response to extraluteal PGF 2␣ .
Overall, the present study strongly supports the emerging concept that, in addition to extraluteal/endometrial sources, locally produced luteal PGs contribute to the regulation of CL function and life span. The information obtained from this study may be particularly relevant to the human, in which extraluteal PGs do not appear to contribute to luteolysis. Our results showing the expression of PGT, PGES, and PGFS open a new research avenue in the field of CL biology. Future studies are required in this arena to unravel the molecular mechanisms involved in the regulation of luteal production and action of PGs. Based on our findings and the available information, we propose a model integrating the role of luteal PGE 2 and PGF 2␣ in maintenance and regression of the CL (Fig. 6 ). Selectively produced luteal PGE 2 and/or PGF 2␣ are transported extracellularly by PGT. Preferential production of PGE 2 and PGF 2␣ during distinct stages of CL life leads to luteal maintenance or demise. After accomplishing biological functions, PGs are transported into cells for metabolism by cellular oxidation. In conclusion, the present data demonstrate the existence of PGE 2 and PGF 2␣ metabolic, transporting, and signaling machineries in CL, suggesting that luteal PGs may contribute to the autoregulation of CL function. [1] [2] [3] [4] , in LLCs AA is metabolized into PGH 2 by COX-1 and COX-2. PGH 2 is then converted into either PGE 2 or PGF 2␣ by PGES or PGFS, respectively. Newly synthesized luteal PGs are transported through the PGT to bring forth their autocrine and paracrine effects on LLCs, SLCs, immune cells (IC), blood vessels (BV), endothelial cells (EC), and smooth muscle cells (SMC). Activation of EP2 and FP increases intracellular cAMP and PKA, and Ca 2ϩ , IP3, and PKC, respectively. EP3 can use either one or both of these signaling pathways depending on the isoform expressed. Autoamplification of luteal PGE 2 or PGF 2␣ production occurs by controlling any of the PG biosynthetic, transporting, and signaling steps. The PGE 2 -EP2 signaling pathway leads to increase in luteal production of P 4 , mitogenesis, angiogenesis, vasodilation, immunomodulation, and decrease in apoptosis and 20␣-HSD activity, thus promoting luteal development, growth, and maintenance. The PGF 2␣ -FP signaling pathway leads to effects opposite to PGE 2 , culminating in luteal regression. Finally, PGs are transported into cells for catabolism by cellular oxidation.
